Industry Trends

Practices › Pharmaceuticals

Pharmaceuticals
Most Promising Segments “Pharmaceuticals”
  • Autologous Stem Cell & Non-stem Cell Therapies Market

    The global autologous stem cell & non-stem cell therapies market, valued at US$3.9B in 2023, is forecasted to grow at a 32.3% CAGR, reaching US$5.5B by 2024 and US$22.2B by 2029. The major factor ...

  • Organ-on-Chip Market

    The global organ-on-chip market, valued at US$89,202T in 2023, is forecasted to grow at a 38.6% CAGR, reaching US$123,285T by 2024 and US$631,073T by 2029. Growth in this market can mainly be att ...

  • Continuous Bioprocessing Market

    The global continuous bioprocessing market, valued at US$201M in 2022, is forecasted to grow at a 22.4% CAGR, reaching US$218M by 2023 and US$599M by 2028. The growth of the market is largely dri ...

  • Oral Proteins & Peptides Market

    The global oral proteins and peptides market, valued at US$8.07 billion in 2024, stood at US$9.31 billion in 2025 and is projected to advance at a resilient CAGR of 16.4% from 2025 to 2030, culmi ...

  • AI in Precision Medicine Market

    The global artificial intelligence in precision medicine market, valued at US$0.60B in 2023, is forecasted to grow at a 30.7% CAGR, reaching US$0.78B by 2024 and US$3.92B by 2030. Growth in preci ...

  • Targeted Protein Degradation Market

    The global targeted protein degradation market, valued at US$0.01 billion in 2024, stood at US$0.48 billion in 2025 and is projected to advance at a resilient CAGR of 35.4% from 2025 to 2035, cul ...

High Impact Segment
  • North American Drug Delivery Technologies Market

    The North American drug delivery technologies market is projected to reach USD 758.7 Billion by 2021 from USD 520.0 Billion in 2016, at a CAGR of 6.5% during the forecast period. Growth in this m ...

  • North America Healthcare IT Market

    The North America healthcare IT market is projected to reach USD 529.06 billion by 2031, growing at a CAGR of 14.3% during the forecast period (2026–2031). The report covers key segments, regio ...

  • Immunotherapy Drugs Market

    The global immunotherapy drugs market, valued at US$255.9B in 2023, is forecasted to grow at a 15.3% CAGR, reaching US$285.3B by 2024 and US$580.6B by 2029. This growth is driven by technological ...

  • Topical Drug Delivery Market

    The global topical drug delivery market, valued at US$247.3 billion in 2024, stood at US$268.4 billion in 2025 and is projected to advance at a resilient CAGR of 8.8% from 2025 to 2030, culminati ...

  • Healthcare Distribution Market

    The healthcare distribution market is projected to reach USD 1,048.4 billion by 2024, at a CAGR of 6.5%. The prominent players operating in the healthcare distribution market are McKesson Corpora ...

  • Monoclonal Antibody Therapeutics Market

    The global monoclonal antibody therapeutics market, valued at US$222.6B in 2023, is forecasted to grow at a 14.5% CAGR, reaching US$252.6B by 2024 and US$497.5B by 2029. Driving factors of the ma ...

Company
  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • SANOFI
  • Pfizer Inc.
  • NOVARTIS
  • HELM AG
  • BAYER AG
  • ASTRAZENECA PLC
  • Merck & Co., Inc.
  • ABBVIE INC.
Company
We can help find ?

Latent demand for you, for your prospective client, or your prospective partners



Our Team

  • Carl Schmidt
    Strategic Consultant Healthcare
  • Shraddha Shrivastava
    Associate Manager Healthcare
  • Vijendra Agarwal
    Associate Manager Healthcare